Quote:Analysis of individual responses from each subject demonstrated that three of the six BIT225-treated individuals demonstrated significant reductions in total HIV-1 DNA levels within their monocytes; the other three subjects’ responses remained unchanged.
A larger, much longer study needs to be done to properly assess BIT225.
BIT225 Phase 2 Study